Squawk on the Street cover image

SOTS 2nd Hour: Alphabet’s Revenue Miss, Musk’s Role in Government, Live: Shell CEO 02/05/25

Squawk on the Street

00:00

Novo Nordisk's Profitable Surge Amidst Stock Struggles

This chapter explores Novo Nordisk's impressive Q4 profits driven by high demand for its WeGoVe obesity drug, which achieved a 107% sales increase. Despite this surge, the company's stock has fallen over 25% for the year, creating a challenging landscape for investors.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app